Rabeprazole and Cortisone acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rabeprazole and Cortisone acetate. Common interactions include toxic epidermal necrolysis among females.

The phase IV clinical study analyzes what interactions people who take Rabeprazole and Cortisone acetate have. It is created by eHealthMe based on reports of 49 people who take Rabeprazole and Cortisone acetate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 18, 2023

49 people who take Rabeprazole and Cortisone acetate together, and have interactions are studied.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 26,157 Rabeprazole users for its effectiveness, alternative drugs and more.

What is Cortisone acetate?

Cortisone acetate has active ingredients of cortisone acetate. It is often used in pain. eHealthMe is studying from 10,164 Cortisone acetate users for its effectiveness, alternative drugs and more.

Number of Rabeprazole and Cortisone acetate reports submitted per year:

Common Rabeprazole and Cortisone Acetate drug interactions by gender *:

female:

Toxic epidermal necrolysis
Septic shock
Rash
Blister
Pyrexia
Abdominal pain upper
Dyspnoea
Rash macular
Mouth ulceration
Rash erythematous

male:

n/a

Common Rabeprazole and Cortisone Acetate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Toxic epidermal necrolysis
Septic shock
Pyrexia
Rash macular
Blister
Mouth ulceration
Rash
Rash erythematous
Skin exfoliation
Skin infection

50-59:

Accidental exposure
Burning sensation
Sensory disturbance

60+:

Ankle fracture
Fall
Gastritis
Hepatic failure
Hepatitis cholestatic
Injection site irritation
Injection site rash
Lower limb fracture
Malaise
Pneumothorax

Common conditions people have *:

Oral Candidiasis (fungal infection of mouth): 25 people, 51.02%
Pneumonia: 23 people, 46.94%
Urine Output - Decreased: 22 people, 44.90%
Urinary Tract Infection: 22 people, 44.90%
Hallucinations (sensations that appear real but are created by your mind): 21 people, 42.86%
Agitation (state of anxiety or nervous excitement): 21 people, 42.86%
Breathing Difficulty: 13 people, 26.53%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 12 people, 24.49%
Renal Impairment (severely reduced kidney function): 11 people, 22.45%
Chondropathy (disease of the cartilage): 7 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and Cortisone acetate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.